Related Experiment Videos
Signalling mechanisms in PAF-induced intestinal failure
Ingmar Lautenschläger1, Yuk Lung Wong2, Jürgen Sarau3
1Department of Anaesthesiology and Intensive Care Medicine, University Medical Centre Schleswig-Holstein, Campus Kiel, Kiel, Germany. ingmar.lautenschlaeger@uksh.de.
Insights
Platelet-activating factor (PAF) causes capillary leakage and gut issues in intensive care. Targeting IP3 receptors or Rho-kinase shows therapeutic promise without negative side effects.
Area of Science:
- Physiology
- Pharmacology
- Intensive Care Medicine
Background:
- Capillary leakage syndrome, vasomotor disturbances, and gut atony are critical issues in intensive care.
- Platelet-activating factor (PAF) is implicated in these conditions, but its signaling mechanisms remain unclear.
- Understanding PAF's role is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the signaling pathways involved in PAF-induced intestinal dysfunction.
- To analyze the roles of calcium, cAMP, myosin light chain kinase, and Rho-kinase in PAF's effects.
- To evaluate potential therapeutic targets for PAF-mediated pathologies.
Main Methods:
- Utilized an isolated perfused rat small intestine model.
- Administered PAF and various inhibitors: calcium deprivation, 2-APB (IP-receptor antagonist), PDE inhibitors, AC activators, ML-7 (MLCK inhibitor), and Y27632 (ROCK inhibitor).
- Assessed PAF-induced vasoconstriction, capillary/mucosal leakage, edema, malabsorption, and atony.
Main Results:
- PAF-induced vasoconstriction and hyperpermeability involve IP3 receptors, extracellular calcium, and Rho-kinase.
- cAMP-elevating treatments reduced hypertension and edema but worsened dysmotility and malabsorption.
- 2-APB and Y27632 improved most PAF-induced malfunctions without adverse effects.
Conclusions:
- PAF-induced intestinal vasoconstriction and hyperpermeability share common signaling pathways.
- Rho-kinase and IP3 receptors are key mediators of PAF's detrimental effects.
- Targeting Rho-kinase or IP3 receptors may offer therapeutic benefits for PAF-related conditions in intensive care.
Abstract:
Capillary leakage syndrome, vasomotor disturbances and gut atony are common clinical problems in intensive care medicine. Various inflammatory mediators and signalling pathways are involved in these pathophysiological alterations among them platelet-activating factor (PAF). The related signalling mechanisms of the PAF-induced dysfunctions are only poorly understood. Here we used the model of the isolated perfused rat small intestine to analyse the role of calcium (using calcium deprivation, IP-receptor blockade (2-APB)), cAMP (PDE-inhibition plus AC activator), myosin light chain kinase (inhibitor ML-7) and Rho-kinase (inhibitor Y27632) in the following PAF-induced malfunctions: vasoconstriction, capillary and mucosal leakage, oedema formation, malabsorption and atony. Among these, the PAF-induced vasoconstriction and hyperpermeability appear to be governed by similar mechanisms that involve IP3 receptors, extracellular calcium and the Rho-kinase. Our findings further suggest that cAMP-elevating treatments - while effective against hypertension and oedema - bear the risk of dysmotility and reduced nutrient uptake. Agents such as 2-APB or Y27632, on the other hand, showed no negative side effects and improved most of the PAF-induced malfunctions suggesting that their therapeutic usefulness should be explored.